RxDoctor Payments DataLook up a doctor →

Eduardo Vasquez, MD

Pulmonary Disease · Miami, FLNPI 1760426597

Payments from drug & device makers

$1,939,507in general payments, 2019–2025

Across 389 payments — averaging $4985.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Chiesi USA, Inc.$1M
  • Pfizer$818K
  • GSK$103K
  • Actelion Pharmaceuticals US, Inc.$58
  • Osprey Medical Inc$22
  • Fidia Pharma USA Inc.$16

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,939,507 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.

See all pulmonary disease providers in Florida

Medicare billing

Part B allowed, 2024
$194,466
Medicare patients
237
Services billed
1,470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →